Literature DB >> 20449807

Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer.

L Yang1, L J Wang, G L Shi, L Ni, C X Song, Z X Zhang, S F Xu.   

Abstract

The primary function of the human leukocyte antigen (HLA) system is to regulate the immune response. Because of its important role in the immune response and its high degree of polymorphism, the HLA system is associated with many diseases. We examined the polymorphisms of HLA-A, B and DRB1 alleles in 100 unrelated patients with lung carcinoma and in 438 unrelated normal controls of Han nationality from North China, using sequence-based typing and PCR with sequence-specific primers. We found that the frequencies of HLA-A*0201, A*2601, B*1518, B*3802, DRB1*0401, DRB1*0402, and DRB1*1201 were higher in the lung carcinoma group than in the normal control group. The P values were 0.035, 0.040, 0.001, 0.017, 0.014, 0.004, and 0.019, respectively, and the odds ratio values were 1.052, 3.513, 4.047, 3.054, 4.237, 19.397, and 2.128, respectively. The frequency of HLA-DRB1*1302 was lower in the lung carcinoma group than in the normal control group (P = 0.046, odds ratio = 0.168). We concluded that patients with lung cancer and healthy controls of Han nationality from North China differ in the frequencies of various HLA alleles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20449807     DOI: 10.4238/vol9-2gmr735

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review.

Authors:  Da-Ping Yu; Xu Cheng; Zhi-Dong Liu; Shao-Fa Xu
Journal:  Oncol Lett       Date:  2017-05-29       Impact factor: 2.967

2.  The association of HLA/KIR genes with non-small cell lung cancer (adenocarcinoma) in a Han Chinese population.

Authors:  Yingfu Li; Shuyuan Liu; Chao Hong; Qianli Ma; Fang Tan; Chengxiu Liu; Piotr Kuśnierczyk; Chuanyin Li; Li Shi; Yufeng Yao
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

3.  Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment.

Authors:  Hao Wang; Sha Zhao; Xiaoshen Zhang; Keyi Jia; Juan Deng; Caicun Zhou; Yayi He
Journal:  Onco Targets Ther       Date:  2019-09-05       Impact factor: 4.147

4.  HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.

Authors:  Huiling Deng; Yuxuan Chen; Jiecong Wang; Ran An
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

5.  Network Pharmacology Approach Reveals the Potential Immune Function Activation and Tumor Cell Apoptosis Promotion of Xia Qi Decoction in Lung Cancer.

Authors:  Song Zhang; Yun Wang
Journal:  Med Sci (Basel)       Date:  2019-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.